1. Search Result

Search Result

Results for "6-Diazo-5-oxo-L-nor-Leucine" in MCE Product Catalog:

Cat. No. Product Name Target Research Areas
  • HY-108357
    6-Diazo-5-oxo-L-nor-Leucine

    L-6-Diazo-5-oxonorLeucine; DON

    Glutaminase Bacterial Influenza Virus Antibiotic Cancer Infection Neurological Disease
    L-6-Diazo-5-oxonorleucine (L-6-Diazo-5-oxonorleucine) is a glutaminases antagonist with a Ki of 6 μM. L-6-Diazo-5-oxonorleucine exhibits analgesic, antibacterial, antiviral and anticancer properties. L-6-Diazo-5-oxonorleucine displays genetic toxicity in vitro. L-6-Diazo-5-oxonorleucine decreases the self-renewal potential and metastatic ability of tumor cell.
  • HY-122218
    JHU-083

    Glutaminase Neurological Disease
    JHU-083, a prodrug of 6-diazo-5-oxo-L-norleucine (DON; HY-108357), is an orally active and selective glutaminase antagonist. JHU-083 blocks glutaminase activity in brain CD11b + cells and experimental cerebral malaria (ECM) resulting in a net decrease of glutamate levels in the animals.